杨超,王珊,李长春,等.卵巢恶性生殖细胞瘤患儿62例治疗结果分析[J].第三军医大学学报,2012,34(18):1877. Yang Chao,Wang Shan,Li Changchun,et al.Outcome of children with malignant ovarian germ cell tumor: a report of 62 cases[J].J Third Mil Med Univ,2012,34(18):1877. [2]杨洁芳,何雄伟.回生口服液对卵巢上皮癌患者化疗毒副反应的影响[J].第三军医大学学报,2015,37(19 ):2000. [3]陈显春,杨英,宋爽,等.乳腺癌患者发生化疗性静脉炎的原因分析及防治对策[J].第三军医大学学报,2007,29(21):2055. [4]斯晓燕,张力.西妥昔单抗联合化疗一线治疗非小细胞肺癌20例临床观察[J].第三军医大学学报,2012,34(20):2063. Si Xiaoyan,Zhang Li.Outcomes of cetuximab combined with chemotherapy as first line therapy in 20 patients with non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(18):2063. [5]罗虎,罗丹,宫亮,等.联合CIK细胞与化疗对比单纯化疗治疗中晚期非小细胞肺癌的Meta分析[J].第三军医大学学报,2012,34(20):2119. [6]徐灵莉,邓本敏,唐玲,等.护理风险管理能有效提高糖尿病合并恶性肿瘤患者的化疗疗效[J].第三军医大学学报,2013,35(04):351. Xu Lingli,Deng Benmin,Tang Ling,et al.Risk management of nursing improves chemotherapy efficiency for diabetic patients with malignant tumor[J].J Third Mil Med Univ,2013,35(18):351. [7]卢先锋,戴楠,杨宇馨,等.血清uPAR的水平与小细胞肺癌化疗疗效及预后的关系[J].第三军医大学学报,2012,34(22):2318. Lu Xianfeng,Dai Nan,Yang Yuxin,et al.Serum uPAR and its relationship with chemosensitivity and prognosis in patients with small cell lung cancer[J].J Third Mil Med Univ,2012,34(18):2318. [8]董华琼,刘发兰,田婕丽,等.回生口服液联合多西紫杉醇同期放化疗治疗60例食管癌临床分析[J].第三军医大学学报,2012,34(24):2473. [9]闫霞,曹官铭,王导新.吉西他滨联合卡铂治疗老年非小细胞肺癌的临床评价[J].第三军医大学学报,2007,29(19):1913. YAN Xia,CAO Guan-min,WANG Dao-xin.Gemcitabine plus carboplatin regimen in treatment of advanced non-small cell lung cancer in aged patients[J].J Third Mil Med Univ,2007,29(18):1913. [10]邓莉,张轩珍,王卫东,等.重组人内皮抑素联合紫杉醇+顺铂化疗方案治疗人乳腺癌？鼠移植瘤的研究[J].第三军医大学学报,2008,30(09):783. DENG Li,ZHANG Xuan-zhen,WANG Wei-dong,et al.Recombinant human endostatin combined with paclitaxel-cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J].J Third Mil Med Univ,2008,30(18):783.
